VEGFA and colorectal carcinoma: For the purpose of establishing the prognostic significance of CXCL7 and VEGF in CRC, the 160 patients were observed to have a median OS time of 67.00 (95% confidence interval [CI]: 61.37–72.63) months and a 5-year survival rate of 62.60% (Figure 4A).